• We are a biotech company in
    infectious diseases with a
    first marketed product.

  • We are dedicated to
    innovation in antibody
    discovery and vaccine R&D.

  • Valneva covers the full
    value chain from bench
    to market.

Welcome to Valneva

Joining forces to create a European biotech leader in vaccines and antibodies

-

— June 30, 2014

Voting results of June 26 AGM
Download PDF  

— Stock information

@valnevase




















-

—News, May 19, 2014

Valneva Announces the First Ever Marketing Approval in Europe for a vaccine produced in the EB66® Cell Line

 All News

— Financial calendar


August 8, 2014
Half-year results (pre-market)

 All dates



May 13, 2014
Valneva Reported its Q1 2014 Results:
Download PR
Download Financial Statements
Download Analysts Presentation
View Webcast

— Upcoming conferences and fairs


October 13 - 15, 2014
World Vaccine Congress Europe
Brussels, Belgium



Meet our Business Development team

map

European biotech company with worldwide presence.

Locations
Please update your browser...